Bunkerhill ECG-EF vs qXR-CTR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by Qure.ai Technologies

AI Verdict

Tool A (Bunkerhill ECG-EF) detects reduced left ventricular ejection fraction from ECGs, aiding in early heart failure identification. Tool B (qXR-CTR) automates cardiothoracic ratio measurement from chest X-rays to assess heart size and potential heart failure risk. While both address heart failure risk, they utilize distinct diagnostic modalities and specific metrics, making them complementary tools rather than direct competitors.

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if you need to rapidly screen for reduced left ventricular ejection fraction (LVEF ≤ 40%) using routine 12-lead electrocardiograms within your existing clinical workflows. This tool is ideal for early identification of heart failure risk in a non-invasive and accessible manner, integrating seamlessly with EHRs to support automated clinical reasoning.

View Bunkerhill ECG-EF →

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is automated and efficient assessment of heart size from chest X-ray images to evaluate potential heart failure risk. This AI-powered solution is well-suited for radiology departments or settings where chest X-rays are a common diagnostic, providing a quick cardiothoracic ratio measurement for initial screening or monitoring.

View qXR-CTR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill ECG-EF qXR-CTR
Pricing Contact sales for pricing details. Contact for pricing
Deployment Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. Cloud, on-premise, hybrid
FDA Status Yes AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill ECG-EF

Bunkerhill ECG-EF is integrated into the broader Carebricks platform, which aims to automate end-to-end workflows and offers features like conversational AI for patient records, suggesting a comprehensive and intuitive user experience. While qXR-CTR seamlessly integrates into radiology workflows and provides robust features for X-ray analysis, Carebricks' wider range of workflow automation and interactive capabilities gives Tool A an edge.

Clinical Value

Bunkerhill ECG-EF

While both tools are FDA-cleared and provide valuable insights for heart failure risk, Bunkerhill ECG-EF's ability to detect reduced LVEF from a routine 12-lead ECG offers a unique and highly accessible screening method for a critical heart failure indicator. This addresses a significant bottleneck in current diagnostic pathways, as echocardiography, the standard for LVEF, requires specialized equipment and expertise.

Pricing & Value

Tie

Both companies require direct contact for pricing information, with neither publicly disclosing their pricing models or transparent cost structures. This lack of transparency makes it impossible to compare their cost-effectiveness or value proposition.

Enterprise Readiness

Bunkerhill ECG-EF

Bunkerhill ECG-EF is part of the Carebricks platform, which is explicitly designed for enterprise-wide deployment, integrating seamlessly with EHRs and clinical archives to automate a wide range of workflows across major health systems like UTMB Health, Cleveland Clinic, and Mayo Clinic. While qXR-CTR offers flexible deployment and integrates well into radiology workflows, the comprehensive, platform-based approach of Carebricks suggests a more robust and scalable solution for diverse enterprise needs.

Innovation

Bunkerhill ECG-EF

Detecting reduced LVEF from a routine 12-lead ECG represents a significant innovation in diagnostic pathways, enabling widespread, non-invasive screening for a major cardiac condition using a readily available and accessible test. While qXR-CTR's automated CTR measurement and multi-finding detection on chest X-rays are valuable, the application of AI to ECGs for LVEF is a newer and potentially more disruptive advancement in cardiac care.

Support & Docs

qXR-CTR

Qure.ai explicitly details a robust support infrastructure, including dedicated client success partners, 24/7 support, email and in-app support features, and comprehensive onboarding and training programs. In contrast, Bunkerhill Health's public presence does not prominently highlight similar dedicated support resources for its ECG-EF product or the broader Carebricks platform.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill ECG-EF qXR-CTR
Name Bunkerhill ECG-EF qXR-CTR
Company BunkerHill Health Qure.ai Technologies
Description (Core Function) Detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead ECGs, aiding in early identification of patients at risk for heart failure. Automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
Primary Data Input Routine 12-lead electrocardiograms (ECGs) Chest X-ray images
Detected Condition/Measurement Reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) Cardiothoracic Ratio (CTR) measurement
Specialties Cardiology, Emergency Medicine, Internal Medicine Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and qXR-CTR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill ECG-EF analyzes routine 12-lead electrocardiograms (ECGs) to detect reduced left ventricular ejection fraction (LVEF u2264 40%). In contrast, qXR-CTR processes chest X-ray images to automate the measurement of the cardiothoracic ratio (CTR).
Bunkerhill ECG-EF is designed to detect reduced left ventricular ejection fraction (LVEF u2264 40%), a key indicator of heart failure. qXR-CTR, on the other hand, automates the measurement of the cardiothoracic ratio (CTR) from chest X-rays, aiding in the assessment of heart size and potential heart failure risk.
Bunkerhill ECG-EF supports Cardiology, Emergency Medicine, and Internal Medicine. qXR-CTR is primarily for Cardiology and Radiology specialties.
Bunkerhill ECG-EF aids in the early identification of patients at risk for heart failure by detecting reduced LVEF from routine ECGs. qXR-CTR assists in the assessment of heart size and potential heart failure risk by automating CTR measurement from chest X-ray images.
AI Tool Finder
AI-powered search. Results may not be comprehensive.